A novel combinatorial strategy using Seliciclib® and Belinostat® for eradication of non-small cell lung cancer via apoptosis induction and BID activation
Journal Article
Publication Work Type:
Research Paper
Magazine \ Newspaper:
Cancer Letters
Volume Number:
381
Pages:
49-57
